Improved survival in an Asian cohort of young colorectal cancer patients: an analysis of 523 patients from a single institution
Authors:
- 23 April 2009
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 24 (9) , 1075-1083
Abstract
Background Colorectal cancer (CRC) in the young is rare. Outcomes remain varied compared to older populations. The study reviews characteristics and overall survival (OS) of CRC in patients ≤50 years old. Materials and methods Five hundred and twenty-three (14%) of 3,796 sporadic CRCs were identified. Patients were compared for demographics, tumour characteristics, treatment, and 5-year overall specific survival. Independent prognostic factors were evaluated. Results The majority were males (54%) with a median age of 45 years (range 19–50 years). Sixty-three percent of the patients presented with advanced stage disease (stage III and IV), and tumours were predominantly left-sided (83%). A higher frequency of mucinous or signet ring cell histological subtypes (16% vs 9%, p = 0.028) as well as poorly differentiated tumours (30% vs 12%, p = 0.0001) were present in younger patients ≤40 years. With a median follow-up of 41 months, the 5-year OS is 58% (95% confidence interval 53–64%). Younger patients ≤40 years had significantly superior 5-year OS of 62% vs 58% in the age group 41–50 years old (p = 0.004). Multivariate analysis identified five independent prognostic features: age group of 41–50 years, poorly differentiated tumour grade, presence of perineural infiltration, high tumour stage, and carcinoembryonic antigen values ≥5 ng/ml. Conclusion This study has revealed significantly improved 5-year survival in young CRC compared to those reported in the literature.Keywords
This publication has 29 references indexed in Scilit:
- Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical useEuropean Journal of Cancer, 2007
- ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal CancerJournal of Clinical Oncology, 2006
- Favorable Influence of Age on Tumor Characteristics of Sporadic Colorectal AdenocarcinomaDiseases of the Colon & Rectum, 2003
- Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancerSeminars in Oncology, 2001
- High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancerDiseases of the Colon & Rectum, 2001
- Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancerSeminars in Oncology, 2001
- Prognostic factors and survival of patients aged less than 45 years with colorectal cancerBritish Journal of Surgery, 1994
- Prevention of colorectal cancer by once-only sigmoidoscopyThe Lancet, 1993
- Colorectal carcinoma in young patientsJournal of Surgical Oncology, 1992
- Colorectal adenocarcinoma in patients less than 40 years of ageDiseases of the Colon & Rectum, 1991